| Literature DB >> 24688431 |
Abdulwali Ablat1, Jamaludin Mohamad1, Khalijah Awang2, Jamil A Shilpi2, Aditya Arya3.
Abstract
The ethanol extract of B. javanica seed was fractionated with solvents of different polarities and tested for antioxidant activities by several assays including DPPH radical scavenging activity, ferric reducing antioxidant power (FRAP), ferrous ion chelating activity (FCA), and nitric oxide radical scavenging activity (NORSA) along with their polyphenolic contents. Antidiabetic activity was evaluated both in vitro and in vivo using a glycogen phosphorylase α (GPα) inhibition assay and oral glucose tolerance test (OGTT) in nondiabetic rats. The ethyl acetate fraction (EAF), rich in tannin, exhibited the strongest antioxidant activities to DPPH, FRAP, and NORSA, except for FCA. The EAF also exerted a dose-depended inhibition of GPα (IC50 = 0.75 mg/ml). Further evaluation of hypoglycemic effect on OGGT indicated that rats treated with EAF (125 mg/kg bw) showed a 39.91% decrease (P < 0.05) in blood glucose levels at 30 min, and continuous fall (P < 0.05) of 28.89% and 20.29% was observed in the following hours (60 and 90 min) compared to the normal control during OGTT. The EAF was applied to polyamide column chromatography, and the resulting tannin-free fraction was tested for both GPα inhibition and antioxidant (DPPH only) activity. The GP α inhibitory activity was retained, while antioxidant activity was lost (4.6-fold) after tannin removal. These results concluded that the GPα inhibitory activity initially detected was primarily due to the compounds other than tannins, whereas antioxidant activity was mainly due to the tannins.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24688431 PMCID: PMC3933519 DOI: 10.1155/2014/786130
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Total phenolic and different classes of polyphenol contents in B. javanica seed.
| Fractions | TFC (mg QE/g) | TPC (mg TAE/g) | TET (mg TAE/g) | NPP (mg TAE/g) |
|---|---|---|---|---|
| HF | 15.60 ± 4.82a | 0.82 ± 0.39a | 0.45 ± 1.50a | 0.37 ± 2.21a |
| CHF | 49.45 ± 4.46b | 119.98 ± 2.58b | 15.02 ± 2.21b | 104.97 ± 4.72b |
| EAF | 154.73 ± 0.61c | 169.03 ± 3.54c | 107.00 ± 1.74c | 62.02 ± 1.50c |
| WF | 33.33 ± 5.77d | 46.71 ± 4.08d | 11.71 ± 5.12d | 34.99 ± 1.75d |
Data are mean ± SE (n = 3). The means with different lower case letters (a, b, c, and d) in the same column are significantly different at P < 0.05 (ANOVA, followed by Duncan's multiple comparison test). TFC: total flavonoid content expressed as mg quercetin equivalent (mg QE)/g of dry extract. TPC: total phenolic content; TET: total extractable tannin; NPP: nonprecipitable phenol contents expressed as mg tannic acid equivalent (mg TAE)/g of dry extract. HF: n-hexane fraction. CHF: chloroform fraction. EAF: ethyl acetate fraction. WF: water fraction.
Antioxidant activities of B. javanica seed.
| Fractions | DPPH (IC50 µg/mL) | FRAP (mmol Fe2+/g extract) | FCA (IC50 µg/mL) | NORSA (IC50 µg/mL) |
|---|---|---|---|---|
| HF | ND | 0.14 ± 0.01a | 93.75 ± 7.75a | ND |
| CHF | ND | 0.24 ± 0.01b | 314.55 ± 5.32b | ND |
| EAF | 33.65 ± 3.04a | 1.64 ± 0.06c | 165.45 ± 5.65c | 86.19 ± 3.83 |
| WF | 184.58 ± 7.31b | 0.20 ± 0.01* | ND | ND |
Data are mean ± SE (n = 3). Means with different lower case letters (a, b, c, and d) in the same column are significantly different at P < 0.05 (ANOVA, followed by Dunnett's multiple comparison test). *P < 0.05 compared to a and c in the same column. DPPH: 2,2 diphenyl-1-picrylhydrazyl. FRAP: ferric reducing antioxidant power. FCA: ferrous ion chelating activity. NORSA: nitric oxide radical scavenging activity. HF: n-hexane fraction. CHF: chloroform fraction. EAF: ethyl acetate fraction. WF: water fraction. ND: not detected.
Figure 1Glycogen phosphorylase α (GPα) inhibition by B. javanica seed. EAF: ethyl acetate fraction. WF: water fraction. HF: hexane fraction. CHF: chloroform fraction. The values are shown in mean ± SE (n = 3).
Figure 2The effect of EAF from B. javanica seed on nondiabetic rats during the oral glucose tolerance test. The values are shown in mean ± SE (n = 6). Group I: normal control (distilled water); Group II: treated with EAF (50 mg/kg bw); Group III: treated with EAF (125 mg/kg bw); Group IV: treated with oral antidiabetic drug glibenclamide (10 mg/kg); all groups orally received glucose (2.0 g/kg bw) at 30 minutes after treatment. *P < 0.05 compared to the control at the corresponding time.